TrialThyroid : official journal of the American Thyroid Association2013

Phase II trial of sorafenib in patients with advanced anaplastic carcinoma of the thyroid.

Panayiotis Savvides et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.